Barclays analyst Andrew Mok lowered the firm’s price target on UnitedHealth (UNH) to $327 from $391 and keeps an Overweight rating on the shares.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- Here’s Why TD Cowen Lowered its UnitedHealth Stock (UNH) Price Target
- UnitedHealth Stock Forecast: Analysts Split As Turnaround Unfolds
- Mixed options sentiment in UnitedHealth with shares up 3.66%
- UnitedHealth price target lowered to $361 from $408 at RBC Capital
- UnitedHealth Stock Forecast: Analysts See Turnaround Upside